Recent advances in phytochemical-based Nano-formulation for drug-resistant Cancer-Reference-Cited by-同舟云学术

Recent advances in phytochemical-based Nano-formulation for drug-resistant Cancer

Published:2021-06 Issue: Volume:10 Page:100082
ISSN:2590-0986
Container-title:Medicine in Drug Discovery
language:en
Short-container-title:Medicine in Drug Discovery

Author:

More Mahesh P.,Pardeshi Sagar R.,Pardeshi Chandrakantsing V.,Sonawane Gaurav A.,Shinde Mahesh N.,Deshmukh Prashant K.,Naik Jitendra B.,Kulkarni Abhijeet D.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Drug Discovery,Pharmacology

Reference114 articles.

1. A multifunctional nanoplatform against multidrug resistant cancer: merging the best of targeted chemo/gene/photothermal therapy;Cheng;Adv Funct Mater,2017

2. Revisiting the role of ABC transporters in multidrug-resistant cancer;Robey;Nat Rev Cancer,2018

3. Phytochemicals in cancer cell chemosensitization: current knowledge and future perspectives;Khatoon;Semin Cancer Biol,2020

4. Interactions of engineered nanoparticles with organs protected by internal biological barriers;Pietroiusti;Small,2013

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the pancreatic tumor microenvironment by plant-derived products and their nanoformulations;Medical Oncology;2024-07-13

2. Nanoparticle‐Based Drug Delivery Platform for Simultaneous Administration of Phytochemicals and Chemotherapeutics: Emerging Trends in Cancer Management;Particle & Particle Systems Characterization;2024-06-28

3. Advantages of Synthesized Nanocarriers from Saltmarsh Phytochemicals and Their Biological Applications;Nanoscience and Nanotechnology for Smart Prevention, Diagnostics and Therapeutics;2024-06-18

4. Phytosynthesis of transition (Ni, Fe, Co, Cr, and Mn) metals and their oxide nanoparticles for biomedical applications: a review;Journal of Materials Science;2024-06

5. The Therapeutic Potential of Harpagophytum procumbens and Turnera subulata and Advances in Nutraceutical Delivery Systems in Neurodegenerative Diseases;Pharmaceuticals;2024-05-20